Novartis (NVSN) Stock Statistics & Valuation Metrics

Novartis has a market cap or net worth of $4.91T. The enterprise value is $341.69K.

Novartis has 2,034,819,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 15.50%.

The current PE Ratio of Novartis is 23.7. Novartis’s PEG ratio is 0.85.

In the last 12 months, Novartis had revenue of 54.81B and earned 14.06B in profits. Earnings per share was 7.25.

In the last 12 months, operating cash flow was 18.39B and capital expenditures -2.57B, giving a free cash flow of 15.82B billion.

Novartis pays an annual dividend of ―, resulting in a dividend yield of ―

Novartis upcoming earnings date is Oct 27, 2026, TBA (Confirmed).

Novartis as a current ratio of 1.12, with Debt / Equity ratio of 117.99%

In the past 12 months, Novartis has paid 2.40B in taxes.

Novartis EV to EBITDA ratio is 12.74, with an EV/FCF ratio of 16.56.

Novartis has $7.69B in cash and marketable securities with $49.01B in debt, giving a net cash position of -$41.32B billion.

Gross margin is 74.29%, with operating margin of 31.15%, and net profit margin of 25.64%.

The average price target for Novartis is $2,775.36, which is 11.43% higher than the current price. The consensus rating is Hold